Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia - Contacts and Locations

Home

Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia

This study is ongoing, but not recruiting participants.

Study NCT00002869. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00002869

Locations


United Kingdom, Scotland
	Western General Hospital
	Edinburgh, Scotland, United Kingdom, EH4 2XU

Sponsors and Collaborators

Medical Research Council

Investigators


Study Chair:	Patricia Shepherd, MD	Edinburgh Cancer Centre at Western General Hospital